Peter Paschka
Impact in
- Hematology top 0.1%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 0.2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 78
- Acute Myeloid Leukemia Research 59
- Chronic Myeloid Leukemia Treatments 33
-
- Protein Degradation and Inhibitors 15
- Histone Deacetylase Inhibitors Research 7
- Co-authors
- Guido Marcucci (28 shared papers)Clara D. Bloomfield (24 shared papers)Krzysztof Mrózek (24 shared papers)Susan P. Whitman (21 shared papers)Richard A. Larson (23 shared papers)Konstanze Döhner (32 shared papers)Jonathan E. Kolitz (18 shared papers)Andrew J. Carroll (11 shared papers)
- Journals
- Blood (37 papers)Journal of Clinical Oncology (22 papers)Leukemia (7 papers)Haematologica (4 papers)Hematology (3 papers)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Peter Paschka
93 papers receiving 6.5k citations
Peter Paschka's Hit Papers
Peers
Comparison fields: 5 of 101
- Hematology 4.7k
- Genetics 1.7k
- Cancer Research 1.3k
- Molecular Biology 3.1k
- Public Health, Environmental and Occupational Health 834
Countries citing papers authored by Peter Paschka
This map shows the geographic impact of Peter Paschka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Paschka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Paschka more than expected).
Fields of papers citing papers by Peter Paschka
This network shows the impact of papers produced by Peter Paschka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Paschka. The network helps show where Peter Paschka may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Paschka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | IDH1andIDH2Mutations Are Frequent Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia WithNPM1Mutation WithoutFLT3Internal Tandem Duplication Hit paper breakdown → | 2010 | 602 |
| 2 | 2006 | 499 | |
| 3 | 2006 | 422 | |
| 4 | 2011 | 352 | |
| 5 | 2008 | 335 | |
| 6 | 2008 | 329 | |
| 7 | 2009 | 257 | |
| 8 | 2008 | 237 | |
| 9 | 2005 | 202 | |
| 10 | 2007 | 201 | |
| 11 | 2005 | 195 | |
| 12 | 2005 | 189 | |
| 13 | 2013 | 187 | |
| 14 | 2008 | 184 | |
| 15 | 2017 | 172 | |
| 16 | 2012 | 152 | |
| 17 | 2007 | 150 | |
| 18 | 2008 | 136 | |
| 19 | 2002 | 128 | |
| 20 | 2009 | 117 |
About Peter Paschka
Peter Paschka is a scholar working on Hematology, Molecular Biology, Genetics, Oncology and Immunology, having authored 97 papers that have together received 6.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (59 papers), Chronic Myeloid Leukemia Treatments (33 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (17 papers), Chronic Lymphocytic Leukemia Research (16 papers), Protein Degradation and Inhibitors (15 papers), Acute Lymphoblastic Leukemia research (11 papers), CAR-T cell therapy research (8 papers) and Histone Deacetylase Inhibitors Research (7 papers). The work is most often cited by research in Hematology (4.7k citations), Genetics (1.7k citations), Cancer Research (1.3k citations), Molecular Biology (3.1k citations) and Public Health, Environmental and Occupational Health (834 citations). Peter Paschka has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Guido Marcucci, Clara D. Bloomfield, Krzysztof Mrózek, Susan P. Whitman, Richard A. Larson, Konstanze Döhner, Jonathan E. Kolitz, Andrew J. Carroll, Hartmut Döhner and Lars Bullinger. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia, Haematologica and Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.